Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. (Q40370839)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

C-J Hong

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

T-J Chen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Y W-Y Yu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

27-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Synthesis of serotonin by a second tryptophan hydroxylase isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

5-HT-1A receptor-mediated effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Serotonin transporter genetic polymorphisms and harm avoidance in the Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Association analysis of a functional G protein beta3 subunit gene polymorphism (C825T) in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Is there a role for 5-HT1A agonists in the treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Differential effectiveness of newer and older antidepressants appears mediated by an age effect on the phenotypic expression of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Gender-specific aging effects on the serotonin 1A receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

7 January 2021

Serotonin transporter gene polymorphism and antidepressant response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

7 January 2021

Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

7 January 2021

Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

7 January 2021

No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

7 January 2021

Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

7 January 2021

A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500340

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16302021%20AND%20SRC:MED&resulttype=core&format=json

release_7mhu2usihjd5zpmuikund7jeku

9 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7mhu2usihjd5zpmuikund7jeku

24 November 2022

mapped directly with Wikidata item

1 reference